In response to the global COVID-19 pandemic, LGC’s Immunogenicity Centre of Excellence have developed and validated a CE marked serological test for the detection of antibody responses to COVID-19 in serum and dried blood collection (Neoteryx Mitra® using an electrochemiluminescence semi-homogenous bridging assay).
For more information please visit lgcgroup.com/dds
